Literature DB >> 18929645

Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter.

Valentina Ghisi1, Amy J Ramsey, Bernard Masri, Raul R Gainetdinov, Marc G Caron, Ali Salahpour.   

Abstract

The dopamine transporter (DAT) regulates the temporal and spatial actions of dopamine by reuptaking this neurotransmitter into the presynaptic neurons. We recently generated transgenic mice overexpressing DAT (DAT-tg) that have a 3-fold increase in DAT protein levels which results in a 40% reduction of the extracellular DA concentration in the striatum. The aim of this study was to examine the effect of this reduction in dopaminergic tone on postsynaptic responses mediated by dopamine receptors. We report here that DAT-tg mice have increased levels of striatal D1 (30%) and D2 (approximately 60%) dopamine receptors with D1 receptor signaling components not significantly altered, as evidenced by unaffected basal or stimulated levels of phospho-GluR1 (Ser845) and phospho-ERK2. However, the novel D2 mediated Akt signaling is markedly altered in DAT-tg animals. In particular, there is a 300% increase in the basal levels of phospho-Akt in the striatum of DAT-tg, reflecting the reduced extracellular dopamine tone in these animals. This increase in basal pAkt levels can be pharmacologically recapitulated by partial dopamine depletion in WT mice treated with the selective tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (alpha-MPT). Behaviorally, DAT-tg animals demonstrate an augmented synergistic interaction between up-regulated D1 and D2 receptors, which results in increased climbing behavior in transgenic mice after stimulation with either apomorphine or a co-administration of selective D1 and D2 receptor agonists. In sum, our study reveals that hypodopaminegia caused by up-regulation of DAT results in significant alterations at postsynaptic receptor function with most notable dysregulation at the level of D2 receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929645      PMCID: PMC3536494          DOI: 10.1016/j.cellsig.2008.09.011

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  37 in total

Review 1.  A paradigm shift in brain research.

Authors:  A Carlsson
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

2.  Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice.

Authors:  Raul R Gainetdinov; Laura M Bohn; Tatyana D Sotnikova; Michel Cyr; Aki Laakso; Alexander D Macrae; Gonzalo E Torres; Kyeong Man Kim; Robert J Lefkowitz; Marc G Caron; Richard T Premont
Journal:  Neuron       Date:  2003-04-24       Impact factor: 17.173

Review 3.  Plasma membrane monoamine transporters: structure, regulation and function.

Authors:  Gonzalo E Torres; Raul R Gainetdinov; Marc G Caron
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

Review 4.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

Review 5.  Monoamine transporter pharmacology and mutant mice.

Authors:  Raul R Gainetdinov; Tatyana D Sotnikova; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

6.  Diverse psychotomimetics act through a common signaling pathway.

Authors:  Per Svenningsson; Eleni T Tzavara; Robert Carruthers; Ilan Rachleff; Sigrid Wattler; Michael Nehls; David L McKinzie; Allen A Fienberg; George G Nomikos; Paul Greengard
Journal:  Science       Date:  2003-11-21       Impact factor: 47.728

Review 7.  Monoamine transporters: from genes to behavior.

Authors:  Raul R Gainetdinov; Marc G Caron
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-09-17       Impact factor: 13.820

8.  Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia.

Authors:  Effat S Emamian; Diana Hall; Morris J Birnbaum; Maria Karayiorgou; Joseph A Gogos
Journal:  Nat Genet       Date:  2004-01-25       Impact factor: 38.330

9.  Apomorphine-induced stereotypic cage climbing in mice as a model for studying changes in dopamine receptor sensitivity.

Authors:  R E Wilcox; R V Smith; J A Anderson; W H Riffee
Journal:  Pharmacol Biochem Behav       Date:  1980-01       Impact factor: 3.533

10.  Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.

Authors:  Jean-Martin Beaulieu; Tatyana D Sotnikova; Wei-Dong Yao; Lisa Kockeritz; James R Woodgett; Raul R Gainetdinov; Marc G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

View more
  20 in total

Review 1.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

2.  Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.

Authors:  Sheraz Khoja; Vivek Shah; Damaris Garcia; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

Review 3.  Dopamine transporter mutant animals: a translational perspective.

Authors:  Evgeniya V Efimova; Raul R Gainetdinov; Evgeny A Budygin; Tatyana D Sotnikova
Journal:  J Neurogenet       Date:  2016-03       Impact factor: 1.250

4.  Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Authors:  Anne-Claude Bédard; Kurt P Schulz; Edwin H Cook; Jin Fan; Suzanne M Clerkin; Iliyan Ivanov; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

5.  Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.

Authors:  S T Masoud; L M Vecchio; Y Bergeron; M M Hossain; L T Nguyen; M K Bermejo; B Kile; T D Sotnikova; W B Siesser; R R Gainetdinov; R M Wightman; M G Caron; J R Richardson; G W Miller; A J Ramsey; M Cyr; A Salahpour
Journal:  Neurobiol Dis       Date:  2014-10-30       Impact factor: 5.996

6.  Deficient serotonin neurotransmission and depression-like serotonin biomarker alterations in tryptophan hydroxylase 2 (Tph2) loss-of-function mice.

Authors:  J P R Jacobsen; W B Siesser; B D Sachs; S Peterson; M J Cools; V Setola; J H A Folgering; G Flik; M G Caron
Journal:  Mol Psychiatry       Date:  2011-05-03       Impact factor: 15.992

Review 7.  Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.

Authors:  Kelly M Lohr; Shababa T Masoud; Ali Salahpour; Gary W Miller
Journal:  Eur J Neurosci       Date:  2016-09-02       Impact factor: 3.386

8.  In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.

Authors:  Alison D Kreisler; Michael J Terranova; Sucharita S Somkuwar; Dvijen C Purohit; Shanshan Wang; Brian P Head; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2020-04-03       Impact factor: 3.270

9.  Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Authors:  Hanna Jaaro-Peled; Minae Niwa; Catherine A Foss; Rina Murai; Samantha de Los Reyes; Atsushi Kamiya; Yolanda Mateo; Patricio O'Donnell; Nicola G Cascella; Toshitaka Nabeshima; Tomás R Guilarte; Martin G Pomper; Akira Sawa
Journal:  Hum Mol Genet       Date:  2013-01-11       Impact factor: 6.150

10.  Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats.

Authors:  James P Kesby; Xiaoying Cui; Jonathan O'Loan; John J McGrath; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2009-11-18       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.